BG
TBIO

Baupost Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Baupost Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,044,239
Closed -$494M – 62
2021
Q2 		$494M Hold
18,044,239
– – 4% 9
2021
Q1 		$296M Hold
18,044,239
– – 2.36% 12
2020
Q4 		$326M Hold
18,044,239
– – 3.01% 10
2020
Q3 		$242M Hold
18,044,239
– – 2.62% 13
2020
Q2 		$319M Buy
18,044,239
+500,000
+3% +$7.54M 3.98% 7
2020
Q1 		$171M Hold
17,544,239
– – 2.53% 14
2019
Q4 		$141M Hold
17,544,239
– – 1.56% 19
2019
Q3 		$172M Buy
17,544,239
+8,700,000
+98% +$82.1M 1.95% 18
2019
Q2 		$109M Buy
8,844,239
+2,352,941
+36% +$24.8M 0.99% 25
2019
Q1 		$63.9M Buy
6,491,298
+11
+0% +$84 0.54% 29
2018
Q4 		$47.1M Hold
6,491,287
– – 0.41% 29
2018
Q3 		$62.4M Buy
6,491,287
+4,568,211
+238% +$53.2M 0.48% 26
2018
Q2 		$24.3M Buy
+1,923,076
New +$23.2M 0.21% 28

Baupost Group's TBIO Position: Q3 2021 in Review

Baupost Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 18,044,239 shares — an estimated $494M sold.

Baupost Group first reported a position in TBIO in Q2 2018 and held it in 13 quarters. The position peaked at $494M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Baupost Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Baupost Group sold 18,044,239 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $494M.
  • Baupost Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
  • Baupost Group's Translate Bio, Inc. Common Stock position peaked at $494M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Baupost Group's 13F filing for Q3 2021, filed 12 Nov 2021.